Back

Blood plasma metabolites and heart failure risk: insights from Mendelian randomization analysis

31 August 2024 (14:30 - 14:40)
Organised by: Logo
Congress Presentation Part of: Markers for the severity of worsening heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ziqi Ma

Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Comparing de novo heart failure and acute decompensated heart failure using a proteomic approach
Mrs A. Dieden (Malmoe, SE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of systemic immune-inflammation index in patients with acute decompensated heart failure with preserved ejection fraction -PURSUIT-HFpEF Registry-
Mr Y. Kokubu (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
VExUS score improvement is associated with better outcomes in acute decompensated heart failure
Doctor M. Saadi (Porto Alegre, BR)
Abstract Slides Video
Presentation thumbnail
Serial shock severity assessment within seventy-two hours after diagnosis: a cardiogenic shock working group report
Doctor V. Ton (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Markers for the severity of worsening heart failure
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Association of genetically predicted human metabolomic gene expression with incident heart failure
thumbnail
Congress Presentation
Non-linear causal effects of kidney function on the risk of heart failure: a Mendelian randomization study
thumbnail
Congress Session
Registries on incident and prevalent heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources